SCHEMBL10489965

SCHEMBL10489965

CC(CN)OC(=O)C(Cl)Cl

nearest known ligand 0.33

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.33
▸ CHRM2 P08172 2/20 0.33
▸ CHRM4 P08173 2/20 0.33
▸ CHRM1 P11229 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ MAPT P10636 1/20 0.32
▸ TBXA2R P21731 1/20 0.30
▸ FAAH O00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16375095 0.79 MAPT (0.41) LMNACHRM2CHRM4CHRM1TSHR
Hydrochloric Acid SCHEMBL3507188 0.79 LMNA (0.34) LMNACHRM2CHRM4CHRM1TSHR
Hydrochloric Acid SCHEMBL3506823 0.79 LMNA (0.34) LMNACHRM2CHRM4CHRM1TSHR
SCHEMBL18274692 0.79 ALDH1A1 (0.35) LMNACHRM2CHRM4CHRM1TSHR
Hydrochloric Acid SCHEMBL3506816 0.79 LMNA (0.34) LMNACHRM2CHRM4CHRM1TSHR
SCHEMBL25142156 0.77 LMNA (0.33) LMNACHRM2CHRM4CHRM1TSHR
Bromide SCHEMBL11516935 0.77 LMNA (0.33) LMNACHRM2CHRM4CHRM1TSHR
SCHEMBL16376236 0.76 FAAH (0.43) LMNACHRM1TSHRCHRM3MAPT
SCHEMBL11346817 0.75 TSHR (0.38) LMNACHRM2CHRM4CHRM1TSHR
SCHEMBL11468912 0.75 TSHR (0.38) LMNACHRM2CHRM4CHRM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-1022810-A — — None — — JP disclosed
US-10022345-B2 Agent for preventing and/or treating veisalgia SBI PHARMACEUTICALS CO., LTD. (JP) 2018-07-17 — — US disclosed
EP-2789336-B1 AGENT FOR PREVENTING AND/OR TREATING HANGOVER SBI PHARMACEUTICALS CO LTD (JP) 2016-12-14 — — EP disclosed
US-20160081957-A1 Agent for Preventing and/or Treating Veisalgia SBI PHARMACEUTICALS CO LTD (JP) 2016-03-24 — — US disclosed
US-20140343140-A1 Agent for Preventing and/or Treating Veisalgia SBI PHARMACEUTICALS CO., LTD. (JP) 2014-11-20 — — US disclosed
EP-2789336-A1 AGENT FOR PREVENTING AND/OR TREATING VEISALGIA SBI Pharmaceuticals Co., Ltd. (JP) 2014-10-15 — — EP disclosed
JP-S6422810-A SKIN COSMETIC KANEBO LTD 1989-01-25 — — JP disclosed
Send feedback